Switch theme
Sign up to access all valuation multiples
Natura Cosmeticos SA is operating mainly in the cosmetics, fragrance, and personal hygiene segments, through the development, manufacture, distribution, and commercialization of its products. The brands managed by the company include the following: Natura, The Body Shop, Avon, and Aesop. In addition to using the retail market, e-commerce, business-to-business (B2B), and franchises as sales channels for the products, the company and its subsidiaries highlight the performance of the direct sales channel carried out by Natura and The Body Shop brands' consultants. Geographically, the group operates in Brazil and also maintains a presence in international markets.
1969
1.2K+
LTM Revenue $5.5B
LTM EBITDA $578M
$2.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Natura Cosmeticos has a last 12-month revenue (LTM) of $5.5B and a last 12-month EBITDA of $578M.
In the most recent fiscal year, Natura Cosmeticos achieved revenue of $3.7B and an EBITDA of $414M.
Natura Cosmeticos expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Natura Cosmeticos valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $5.5B | XXX | $3.7B | XXX | XXX | XXX |
| Gross Profit | $3.5B | XXX | $2.6B | XXX | XXX | XXX |
| Gross Margin | 64% | XXX | 71% | XXX | XXX | XXX |
| EBITDA | $578M | XXX | $414M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBIT | $240M | XXX | $374M | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | -$567M | XXX | $22.8M | XXX | XXX | XXX |
| Net Margin | -10% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.0B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Natura Cosmeticos's stock price is BRL 9 (or $2).
Natura Cosmeticos has current market cap of BRL 12.5B (or $2.3B), and EV of BRL 13.3B (or $2.4B).
See Natura Cosmeticos trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.4B | $2.3B | XXX | XXX | XXX | XXX | $0.04 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Natura Cosmeticos has market cap of $2.3B and EV of $2.4B.
Natura Cosmeticos's trades at 0.7x EV/Revenue multiple, and 5.9x EV/EBITDA.
Equity research analysts estimate Natura Cosmeticos's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Natura Cosmeticos has a P/E ratio of -4.1x.
See valuation multiples for Natura Cosmeticos and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.3B | XXX | $2.3B | XXX | XXX | XXX |
| EV (current) | $2.4B | XXX | $2.4B | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | 4.2x | XXX | 5.9x | XXX | XXX | XXX |
| EV/EBIT | 10.2x | XXX | 6.5x | XXX | XXX | XXX |
| EV/Gross Profit | 0.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | -4.1x | XXX | 101.4x | XXX | XXX | XXX |
| EV/FCF | -12.9x | XXX | 25.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNatura Cosmeticos's last 12 month revenue growth is 6%
Natura Cosmeticos's revenue per employee in the last FY averaged $3.0M, while opex per employee averaged $1.8M for the same period.
Natura Cosmeticos's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Natura Cosmeticos's rule of X is 25% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Natura Cosmeticos and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 25% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | -3% | XXX | XXX | XXX |
| Rule of 40 | 22% | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 25% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $3.0M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $1.8M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 27% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 61% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| SynBiotic | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Natura Cosmeticos acquired XXX companies to date.
Last acquisition by Natura Cosmeticos was XXXXXXXX, XXXXX XXXXX XXXXXX . Natura Cosmeticos acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Natura Cosmeticos founded? | Natura Cosmeticos was founded in 1969. |
| Where is Natura Cosmeticos headquartered? | Natura Cosmeticos is headquartered in Brazil. |
| How many employees does Natura Cosmeticos have? | As of today, Natura Cosmeticos has 1.2K+ employees. |
| Is Natura Cosmeticos publicy listed? | Yes, Natura Cosmeticos is a public company listed on BVMF. |
| What is the stock symbol of Natura Cosmeticos? | Natura Cosmeticos trades under NATU3 ticker. |
| When did Natura Cosmeticos go public? | Natura Cosmeticos went public in 2004. |
| Who are competitors of Natura Cosmeticos? | Similar companies to Natura Cosmeticos include e.g. Acme United, EZZ Life Science, Lavipharm, Sarantis Group. |
| What is the current market cap of Natura Cosmeticos? | Natura Cosmeticos's current market cap is $2.3B |
| What is the current revenue of Natura Cosmeticos? | Natura Cosmeticos's last 12 months revenue is $5.5B. |
| What is the current revenue growth of Natura Cosmeticos? | Natura Cosmeticos revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Natura Cosmeticos? | Current revenue multiple of Natura Cosmeticos is 0.4x. |
| Is Natura Cosmeticos profitable? | Yes, Natura Cosmeticos is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Natura Cosmeticos? | Natura Cosmeticos's last 12 months EBITDA is $578M. |
| What is Natura Cosmeticos's EBITDA margin? | Natura Cosmeticos's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Natura Cosmeticos? | Current EBITDA multiple of Natura Cosmeticos is 4.2x. |
| What is the current FCF of Natura Cosmeticos? | Natura Cosmeticos's last 12 months FCF is -$189M. |
| What is Natura Cosmeticos's FCF margin? | Natura Cosmeticos's last 12 months FCF margin is -3%. |
| What is the current EV/FCF multiple of Natura Cosmeticos? | Current FCF multiple of Natura Cosmeticos is -12.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
